Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36219809

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Feb 1
First author
Harrington KJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Cancer Res. 2023 May 31;12(5):1363-1367. doi: 10.21037/tcr-23-48.
    note
    Source null
    related pmid
    37304541
    relationship
    Comment in

Authors and identifiers

  1. name
    Harrington KJ
    type
    Author
  2. name
    Burtness B
    type
    Author
  3. name
    Greil R
    type
    Author
  4. name
    Soulières D
    type
    Author
  5. name
    Tahara M
    type
    Author
  6. name
    de Castro G Jr
    type
    Author
  7. name
    Psyrri A
    type
    Author
  8. name
    Brana I
    type
    Author
  9. name
    Basté N
    type
    Author
  10. name
    Neupane P
    type
    Author
  11. name
    Bratland Å
    type
    Author
  12. name
    Fuereder T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Harrington KJ
    type
    Author
  2. name
    Burtness B
    type
    Author
  3. name
    Greil R
    type
    Author
  4. name
    Soulières D
    type
    Author
  5. name
    Tahara M
    type
    Author
  6. name
    de Castro G Jr
    type
    Author
  7. name
    Psyrri A
    type
    Author
  8. name
    Brana I
    type
    Author
  9. name
    Basté N
    type
    Author
  10. name
    Neupane P
    type
    Author
  11. name
    Bratland Å
    type
    Author
  12. name
    Fuereder T
    type
    Author
bibliography ids
  1. nci-bib-f985f4849b302f8bbcd43633
book metadata
content sha256
df7703ef5d1cb4c3174d71664068005fb6bb47ae7d744f3bce5eb976faa8b6a6
document type
citation
dois
  1. 10.1200/JCO.21.02508
electronic publication date
display
2022 Oct 11
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36219809
immutable id
pubmed:36219809@df7703ef5d1cb4c3174d71664068005fb6bb47ae7d744f3bce5eb976faa8b6a6
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
4
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
790-802
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Cancer Res. 2023 May 31;12(5):1363-1367. doi: 10.21037/tcr-23-48.
    note
    Source null
    related pmid
    37304541
    relationship
    Comment in
outcomes validated
false
pmid
36219809
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
f358399b1b37f3756f43dbc8201d32fe984b50cf57556a943036f12594646f61
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Feb 1
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36219809/
title
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.

Preserved source evidence · Not medical advice